Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study.

Abstract

OBJECTIVE The presence of systemic and/or immune manifestations in myelodysplasia has been currently reported. The influence of these manifestations on the natural outcome of myelodysplastic syndrome has to be considered. We present a multicenter retrospective study (2002-2009) of patients with myelodysplastic syndrome disclosing systemic and/or immune manifestations. METHODS Forty-six patients with myelodysplasia presenting with systemic and/or immune manifestations were compared in terms of survival with 189 patients with myelodysplasia lacking these features. RESULTS The clinical picture in these cases consisted of fever (13%), arthralgia or arthritis (13%), and cutaneous manifestations (67%). Four cases of systemic vasculitis have been reported in our series, and they have a worse prognosis. Immune anomalies were recorded in 29% of the cases, and the presence of cryoglobulins was also associated with a worse prognosis. CONCLUSION A difference in survival between patients with myelodysplastic syndrome with systemic manifestations and patients lacking these manifestations has been observed in the presence of systemic vasculitis and/or cryoglobulins.

DOI: 10.1002/acr.20504

4 Figures and Tables

02040201220132014201520162017
Citations per Year

53 Citations

Semantic Scholar estimates that this publication has 53 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Hollanda2011SystemicAI, title={Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study.}, author={Ana M de Hollanda and A Beucher and Daniel Henrion and Ayman Ghali and Christian Lavigne and Herv{\'e} L{\'e}vesque and Mohamed Amine Hamidou and J F Subra and Norbert Ifrah and Cristina C Belizna}, journal={Arthritis care & research}, year={2011}, volume={63 8}, pages={1188-94} }